Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis-Reference-Cited by-同舟云学术

Long-Term Effect of Switching From an Anti-CGRP Receptor to an Anti-CGRP Ligand Antibody in Treatment-Refractory Chronic Migraine: A Prospective Real-World Analysis

Published:2023-09 Issue:5 Volume:20 Page:1284-1293
ISSN:1878-7479
Container-title:Neurotherapeutics
language:en
Short-container-title:Neurotherapeutics

Author:

Lambru Giorgio^ORCID,Caponnetto Valeria,Hill Bethany,Ratti Susanna,Sacco Simona,Murphy Madeleine,Briscoe Jessica,Andreou Anna P.

Publisher

Elsevier BV

Subject

Pharmacology (medical),Neurology (clinical),Pharmacology

Link

https://link.springer.com/content/pdf/10.1007/s13311-023-01394-0.pdf

Reference31 articles.

1. Global prevalence of chronic migraine: a systematic review;Natoli;Cephalalgia,2010

2. Impact of depression and anxiety on burden and management of episodic and chronic headaches - a cross-sectional multicentre study in eight Austrian headache centres;Zebenholzer;J Headache Pain,2016

3. Migraine prevalence, disease burden, and the need for preventive therapy;Lipton;Neurology,2007

4. A narrative review on the burden of migraine: when the burden is the impact on people's life;Leonardi;J Headache Pain,2019

5. Emerging drugs for migraine treatment: an update;Lambru;Expert Opin Emerg Drugs,2018

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Switching of monoclonal antibodies against the calcitonin gene-related peptide or its receptor in migraine. Results from a Spanish Cohort;Neurology Perspectives;2024-10

2. Documento de consenso de la Sociedad Española de Neurología (SEN), Sociedad Española de Medicina de Familia y Comunitaria (SEMFYC), Sociedad de Medicina de Atención Primaria (SEMERGEN) y Asociación Española de Migraña y Cefalea (AEMICE) sobre el tratamiento de la migraña;Medicina Clínica;2024-08

3. Migraine treatment consensus document of the Spanish Society of Neurology (SEN), Spanish Society of Family and Community Medicine (SEMFYC), Society of Primary Care Medicine (SEMERGEN) and Spanish Association of Migraine and Headache (AEMICE) on migraine treatment;Medicina Clínica (English Edition);2024-08

4. Impact of duration of chronic migraine on long‐term effectiveness of monoclonal antibodies targeting the calcitonin gene‐related peptide pathway—A real‐world study;Headache: The Journal of Head and Face Pain;2024-07-16

5. Therapeutic patterns and migraine disease burden in switchers of CGRP-targeted monoclonal antibodies – insights from the German NeuroTransData registry;The Journal of Headache and Pain;2024-06-03